BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15956593)

  • 1. Analysis of foot-and-mouth disease virus internalization events in cultured cells.
    O'Donnell V; LaRocco M; Duque H; Baxt B
    J Virol; 2005 Jul; 79(13):8506-18. PubMed ID: 15956593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naïve and infected cattle.
    O'Donnell V; Pacheco JM; Gregg D; Baxt B
    J Comp Pathol; 2009; 141(2-3):98-112. PubMed ID: 19515380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.
    Duque H; LaRocco M; Golde WT; Baxt B
    J Virol; 2004 Sep; 78(18):9773-81. PubMed ID: 15331710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular receptors for foot and mouth disease virus.
    Ruiz-Sáenz J; Goez Y; Tabares W; López-Herrera A
    Intervirology; 2009; 52(4):201-12. PubMed ID: 19556802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells.
    Storey P; Theron J; Maree FF; O'Neill HG
    Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol.
    Martín-Acebes MA; González-Magaldi M; Sandvig K; Sobrino F; Armas-Portela R
    Virology; 2007 Dec; 369(1):105-18. PubMed ID: 17714753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
    Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
    Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis.
    O'Donnell V; Larocco M; Baxt B
    J Virol; 2008 Sep; 82(18):9075-85. PubMed ID: 18614639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus.
    Berryman S; Clark S; Monaghan P; Jackson T
    J Virol; 2005 Jul; 79(13):8519-34. PubMed ID: 15956594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle.
    Rieder E; Henry T; Duque H; Baxt B
    J Virol; 2005 Oct; 79(20):12989-98. PubMed ID: 16189001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus.
    Martín-Acebes MA; González-Magaldi M; Rosas MF; Borrego B; Brocchi E; Armas-Portela R; Sobrino F
    Virology; 2008 May; 374(2):432-43. PubMed ID: 18279902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.
    Duque H; Baxt B
    J Virol; 2003 Feb; 77(4):2500-11. PubMed ID: 12551988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell density-dependent expression of viral antigens during persistence of foot-and-mouth disease virus in cell culture.
    Martín-Acebes MA; Herrera M; Armas-Portela R; Domingo E; Sobrino F
    Virology; 2010 Jul; 403(1):47-55. PubMed ID: 20444479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus.
    Rosas MF; Vieira YA; Postigo R; Martín-Acebes MA; Armas-Portela R; Martínez-Salas E; Sobrino F
    Virology; 2008 Oct; 380(1):34-45. PubMed ID: 18694581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport.
    Moffat K; Howell G; Knox C; Belsham GJ; Monaghan P; Ryan MD; Wileman T
    J Virol; 2005 Apr; 79(7):4382-95. PubMed ID: 15767438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry of human parechovirus 1.
    Joki-Korpela P; Marjomäki V; Krogerus C; Heino J; Hyypiä T
    J Virol; 2001 Feb; 75(4):1958-67. PubMed ID: 11160695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alphaVbeta6 is a high-affinity receptor for coxsackievirus A9.
    Heikkilä O; Susi P; Stanway G; Hyypiä T
    J Gen Virol; 2009 Jan; 90(Pt 1):197-204. PubMed ID: 19088289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes.
    Joshi G; Sharma R; Kakker NK
    Vaccine; 2009 Nov; 27(48):6656-61. PubMed ID: 19751690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome.
    Mohapatra JK; Sanyal A; Hemadri D; Tosh C; Kumar RM; Bandyopadhyay SK
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1133-8. PubMed ID: 15752771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.